MyFinsight
Home
Blog
About
Contact
Redemption of marketable
debt securities
$27,361K
Net cash provided by
investing activities
$16,369K
Canceled cashflow
$10,992K
Net decrease in
cash, cash...
-$9,656K
Canceled cashflow
$16,369K
Accrued expenses and
other current...
$1,232K
Stock-based compensation
$1,210K
Prepaid expenses and
other current assets
-$694K
Depreciation and
amortization
$459K
Non-cash operating lease
expense
$228K
Purchase of marketable
debt securities
$10,992K
Net cash used in
operating activities
-$26,000K
Canceled cashflow
$3,823K
Net cash used in
financing activities
-$25K
Net loss
-$23,272K
Accounts payable
-$5,896K
Operating lease
liabilities
-$396K
Accretion of discount on
marketable debt securities
$239K
Other
$20K
Tax withholding
payments related to net...
$25K
Back
Back
Cash Flow
Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS)
source: myfinsight.com